Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Underexpression of hepatocyte nuclear factor-1β in chromophobe renal cell carcinoma.

Wang CC, Mao TL, Yang WC, Jeng YM.

Histopathology. 2013 Mar;62(4):589-94. doi: 10.1111/his.12026. Epub 2012 Dec 12.

PMID:
23237209
2.

HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies.

Conner JR, Hirsch MS, Jo VY.

Cancer Cytopathol. 2015 May;123(5):298-305. doi: 10.1002/cncy.21530. Epub 2015 Mar 4.

3.

Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.

Kuehn A, Paner GP, Skinnider BF, Cohen C, Datta MW, Young AN, Srigley JR, Amin MB.

Am J Surg Pathol. 2007 Oct;31(10):1528-33.

PMID:
17895753
4.

DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.

Zhao W, Tian B, Wu C, Peng Y, Wang H, Gu WL, Gao FH.

Pathol Res Pract. 2015 Apr;211(4):303-7. doi: 10.1016/j.prp.2014.12.014. Epub 2014 Dec 30.

PMID:
25596994
5.

Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study.

Mazal PR, Stichenwirth M, Koller A, Blach S, Haitel A, Susani M.

Mod Pathol. 2005 Apr;18(4):535-40.

6.

KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms.

Petit A, Castillo M, Santos M, Mellado B, Alcover JB, Mallofré C.

Am J Surg Pathol. 2004 May;28(5):676-8.

PMID:
15105658
7.

Differential expression of caveolin-1 in renal neoplasms.

Tamaskar I, Choueiri TK, Sercia L, Rini B, Bukowski R, Zhou M.

Cancer. 2007 Aug 15;110(4):776-82.

8.

Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms.

Shen SS, Krishna B, Chirala R, Amato RJ, Truong LD.

Mod Pathol. 2005 Jul;18(7):933-40.

9.

Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study.

Lin BT, Brynes RK, Gelb AB, McCourty A, Amin MB, Medeiros LJ.

Mod Pathol. 1998 Nov;11(11):1075-81.

PMID:
9831205
10.

Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.

Bing Z, Lal P, Lu S, Ziober A, Tomaszewski JE.

Ann Diagn Pathol. 2013 Feb;17(1):58-62. doi: 10.1016/j.anndiagpath.2012.07.002. Epub 2012 Aug 14.

PMID:
22898056
11.

Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma.

Mazal PR, Exner M, Haitel A, Krieger S, Thomson RB, Aronson PS, Susani M.

Hum Pathol. 2005 Jan;36(1):22-8.

PMID:
15712178
12.

Expression of S-100 protein in renal cell neoplasms.

Lin F, Yang W, Betten M, Teh BT, Yang XJ; French Kidney Cancer Study Group.

Hum Pathol. 2006 Apr;37(4):462-70.

PMID:
16564922
13.
14.

Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study.

Yakirevich E, Matoso A, Sabo E, Wang LJ, Tavares R, Meitner P, Morris DJ, Pareek G, Delellis RA, Resnick MB.

Hum Pathol. 2011 Nov;42(11):1684-92. doi: 10.1016/j.humpath.2011.01.014. Epub 2011 Apr 29.

PMID:
21531004
15.

Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications.

Kruck S, Hennenlotter J, Vogel U, Schilling D, Gakis G, Hevler J, Kuehs U, Stenzl A, Schwentner C.

BJU Int. 2012 Feb;109(4):634-8. doi: 10.1111/j.1464-410X.2011.10392.x. Epub 2011 Jun 28.

16.

CD10+ and CK7/RON- immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers.

Yasir S, Herrera L, Gomez-Fernandez C, Reis IM, Umar S, Leveillee R, Kava B, Jorda M.

Appl Immunohistochem Mol Morphol. 2012 Oct;20(5):454-61. doi: 10.1097/PAI.0b013e31823fecd3.

PMID:
22417859
17.

Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.

Osunkoya AO, Cohen C, Lawson D, Picken MM, Amin MB, Young AN.

Hum Pathol. 2009 Feb;40(2):206-10. doi: 10.1016/j.humpath.2008.07.002. Epub 2008 Sep 16.

PMID:
18799195
18.

Ghrelin expression in normal kidney tissue and renal carcinomas.

Dagli AF, Aydin S, Karaoglu A, Akpolat N, Ozercan IH, Ozercan MR.

Pathol Res Pract. 2009;205(3):165-73. doi: 10.1016/j.prp.2008.10.002. Epub 2008 Dec 2.

PMID:
19054628
19.

Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma.

Mai KT, Teo I, Belanger EC, Robertson SJ, Marginean EC, Islam S.

Histopathology. 2008 Feb;52(3):277-82. Epub 2007 Dec 13.

PMID:
18081814
20.

Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells.

Kao YC, Lin MC, Lin WC, Jeng YM, Mao TL.

Histopathology. 2012 Nov;61(5):760-8. doi: 10.1111/j.1365-2559.2012.04267.x. Epub 2012 Jul 2.

PMID:
22747504

Supplemental Content

Support Center